TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Plasma-derived Medical Product Market, Global Outlook and Forecast 2025-2032

Plasma-derived Medical Product Market, Global Outlook and Forecast 2025-2032

  • Category:Life Sciences
  • Published on : 25 March 2025
  • Pages :151
  • Formats:
  • Report Code:SMR-8037147

The global Plasma-derived Medical Product market size was estimated at USD 30330 million in 2024 and is projected to reach USD 54496.75 million by 2032, exhibiting a CAGR of 7.60% during the forecast period.

North America Plasma-derived Medical Product market size was estimated at USD 8966.33 million in 2024, at a CAGR of 6.51% during the forecast period of 2025 through 2032.

PlasmaderivedMedicalProductmarket

Report Overview

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation

This report provides a deep insight into the global Plasma-derived Medical Product market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma-derived Medical Product Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma-derived Medical Product market in any manner.

Global Plasma-derived Medical Product Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Boya Bio
  • Yuanda Shuyang
  • Weiguang Bio
  • Nanyue Bio
  • KM Biologics


Market Segmentation (by Type)

  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Others

Market Segmentation (by Application)

  • Hospital
  • Retail Pharmacy
  • Others

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

FAQs on the Global Plasma-Derived Medical Product Market (2024-2032)

1. What is the market size of the Plasma-Derived Medical Product market in 2024?

  • The global Plasma-Derived Medical Product market is valued at USD 30,330 million in 2024.

2. What is the projected market size by 2032?

  • The market is expected to reach USD 58,638.50 million by 2032, growing at a CAGR of 7.60% during the forecast period.

3. What are Plasma-Derived Medical Products?

  • Plasma-derived medical products are therapeutic substances derived from human blood plasma. They are used to treat immune deficiencies, hemophilia, and other blood-related disorders.

4. What factors are driving the growth of this market?

  • Rising demand for plasma-derived therapies
  • Increase in immune disorders & bleeding disorders
  • Growing blood & plasma donation programs
  • Advancements in plasma fractionation technology
  • Government support & reimbursement policies

5. What challenges does the market face?

  • High cost of plasma collection & processing
  • Strict regulatory approvals & quality control
  • Limited availability of blood plasma donors
  • Risk of contamination & infectious disease transmission

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Plasma-derived Medical Product Market
  • Overview of the regional outlook of the Plasma-derived Medical Product Market:

Key Reasons to Buy this Report:

  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support

Customization of the Report

  • In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

  • Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
  • Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma-derived Medical Product Market and its likely evolution in the short to mid-term, and long term.
  • Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
  • Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
  • Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 9 shares the main producing countries of Plasma-derived Medical Product, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
  • Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
  • Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
  • Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
  • Chapter 13 is the main points and conclusions of the report.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Plasma-derived Medical Product
1.2 Key Market Segments
1.2.1 Plasma-derived Medical Product Segment by Type
1.2.2 Plasma-derived Medical Product Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Plasma-derived Medical Product Market Overview
2.1 Global Market Overview
2.1.1 Global Plasma-derived Medical Product Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Plasma-derived Medical Product Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Plasma-derived Medical Product Market Competitive Landscape
3.1 Global Plasma-derived Medical Product Sales by Manufacturers (2019-2025)
3.2 Global Plasma-derived Medical Product Revenue Market Share by Manufacturers (2019-2025)
3.3 Plasma-derived Medical Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Plasma-derived Medical Product Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Plasma-derived Medical Product Sales Sites, Area Served, Product Type
3.6 Plasma-derived Medical Product Market Competitive Situation and Trends
3.6.1 Plasma-derived Medical Product Market Concentration Rate
3.6.2 Global 5 and 10 Largest Plasma-derived Medical Product Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Plasma-derived Medical Product Industry Chain Analysis
4.1 Plasma-derived Medical Product Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Plasma-derived Medical Product Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Plasma-derived Medical Product Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma-derived Medical Product Sales Market Share by Type (2019-2025)
6.3 Global Plasma-derived Medical Product Market Size Market Share by Type (2019-2025)
6.4 Global Plasma-derived Medical Product Price by Type (2019-2025)
7 Plasma-derived Medical Product Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma-derived Medical Product Market Sales by Application (2019-2025)
7.3 Global Plasma-derived Medical Product Market Size (M USD) by Application (2019-2025)
7.4 Global Plasma-derived Medical Product Sales Growth Rate by Application (2019-2025)
8 Plasma-derived Medical Product Market Consumption by Region
8.1 Global Plasma-derived Medical Product Sales by Region
8.1.1 Global Plasma-derived Medical Product Sales by Region
8.1.2 Global Plasma-derived Medical Product Sales Market Share by Region
8.2 North America
8.2.1 North America Plasma-derived Medical Product Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Plasma-derived Medical Product Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Plasma-derived Medical Product Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Plasma-derived Medical Product Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Plasma-derived Medical Product Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Plasma-derived Medical Product Market Production by Region
9.1 Global Production of Plasma-derived Medical Product by Region (2019-2025)
9.2 Global Plasma-derived Medical Product Revenue Market Share by Region (2019-2025)
9.3 Global Plasma-derived Medical Product Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Plasma-derived Medical Product Production
9.4.1 North America Plasma-derived Medical Product Production Growth Rate (2019-2025)
9.4.2 North America Plasma-derived Medical Product Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Plasma-derived Medical Product Production
9.5.1 Europe Plasma-derived Medical Product Production Growth Rate (2019-2025)
9.5.2 Europe Plasma-derived Medical Product Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Plasma-derived Medical Product Production (2019-2025)
9.6.1 Japan Plasma-derived Medical Product Production Growth Rate (2019-2025)
9.6.2 Japan Plasma-derived Medical Product Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Plasma-derived Medical Product Production (2019-2025)
9.7.1 China Plasma-derived Medical Product Production Growth Rate (2019-2025)
9.7.2 China Plasma-derived Medical Product Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Takeda
10.1.1 Takeda Plasma-derived Medical Product Basic Information
10.1.2 Takeda Plasma-derived Medical Product Product Overview
10.1.3 Takeda Plasma-derived Medical Product Product Market Performance
10.1.4 Takeda Business Overview
10.1.5 Takeda Plasma-derived Medical Product SWOT Analysis
10.1.6 Takeda Recent Developments
10.2 CSL
10.2.1 CSL Plasma-derived Medical Product Basic Information
10.2.2 CSL Plasma-derived Medical Product Product Overview
10.2.3 CSL Plasma-derived Medical Product Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL Plasma-derived Medical Product SWOT Analysis
10.2.6 CSL Recent Developments
10.3 Grifols
10.3.1 Grifols Plasma-derived Medical Product Basic Information
10.3.2 Grifols Plasma-derived Medical Product Product Overview
10.3.3 Grifols Plasma-derived Medical Product Product Market Performance
10.3.4 Grifols Plasma-derived Medical Product SWOT Analysis
10.3.5 Grifols Business Overview
10.3.6 Grifols Recent Developments
10.4 Octapharma
10.4.1 Octapharma Plasma-derived Medical Product Basic Information
10.4.2 Octapharma Plasma-derived Medical Product Product Overview
10.4.3 Octapharma Plasma-derived Medical Product Product Market Performance
10.4.4 Octapharma Business Overview
10.4.5 Octapharma Recent Developments
10.5 Kedrion
10.5.1 Kedrion Plasma-derived Medical Product Basic Information
10.5.2 Kedrion Plasma-derived Medical Product Product Overview
10.5.3 Kedrion Plasma-derived Medical Product Product Market Performance
10.5.4 Kedrion Business Overview
10.5.5 Kedrion Recent Developments
10.6 LFB Group
10.6.1 LFB Group Plasma-derived Medical Product Basic Information
10.6.2 LFB Group Plasma-derived Medical Product Product Overview
10.6.3 LFB Group Plasma-derived Medical Product Product Market Performance
10.6.4 LFB Group Business Overview
10.6.5 LFB Group Recent Developments
10.7 Biotest
10.7.1 Biotest Plasma-derived Medical Product Basic Information
10.7.2 Biotest Plasma-derived Medical Product Product Overview
10.7.3 Biotest Plasma-derived Medical Product Product Market Performance
10.7.4 Biotest Business Overview
10.7.5 Biotest Recent Developments
10.8 BPL
10.8.1 BPL Plasma-derived Medical Product Basic Information
10.8.2 BPL Plasma-derived Medical Product Product Overview
10.8.3 BPL Plasma-derived Medical Product Product Market Performance
10.8.4 BPL Business Overview
10.8.5 BPL Recent Developments
10.9 RAAS
10.9.1 RAAS Plasma-derived Medical Product Basic Information
10.9.2 RAAS Plasma-derived Medical Product Product Overview
10.9.3 RAAS Plasma-derived Medical Product Product Market Performance
10.9.4 RAAS Business Overview
10.9.5 RAAS Recent Developments
10.10 CBPO
10.10.1 CBPO Plasma-derived Medical Product Basic Information
10.10.2 CBPO Plasma-derived Medical Product Product Overview
10.10.3 CBPO Plasma-derived Medical Product Product Market Performance
10.10.4 CBPO Business Overview
10.10.5 CBPO Recent Developments
10.11 Hualan Bio
10.11.1 Hualan Bio Plasma-derived Medical Product Basic Information
10.11.2 Hualan Bio Plasma-derived Medical Product Product Overview
10.11.3 Hualan Bio Plasma-derived Medical Product Product Market Performance
10.11.4 Hualan Bio Business Overview
10.11.5 Hualan Bio Recent Developments
10.12 Tiantan Bio
10.12.1 Tiantan Bio Plasma-derived Medical Product Basic Information
10.12.2 Tiantan Bio Plasma-derived Medical Product Product Overview
10.12.3 Tiantan Bio Plasma-derived Medical Product Product Market Performance
10.12.4 Tiantan Bio Business Overview
10.12.5 Tiantan Bio Recent Developments
10.13 Shuanglin Bio
10.13.1 Shuanglin Bio Plasma-derived Medical Product Basic Information
10.13.2 Shuanglin Bio Plasma-derived Medical Product Product Overview
10.13.3 Shuanglin Bio Plasma-derived Medical Product Product Market Performance
10.13.4 Shuanglin Bio Business Overview
10.13.5 Shuanglin Bio Recent Developments
10.14 Boya Bio
10.14.1 Boya Bio Plasma-derived Medical Product Basic Information
10.14.2 Boya Bio Plasma-derived Medical Product Product Overview
10.14.3 Boya Bio Plasma-derived Medical Product Product Market Performance
10.14.4 Boya Bio Business Overview
10.14.5 Boya Bio Recent Developments
10.15 Yuanda Shuyang
10.15.1 Yuanda Shuyang Plasma-derived Medical Product Basic Information
10.15.2 Yuanda Shuyang Plasma-derived Medical Product Product Overview
10.15.3 Yuanda Shuyang Plasma-derived Medical Product Product Market Performance
10.15.4 Yuanda Shuyang Business Overview
10.15.5 Yuanda Shuyang Recent Developments
10.16 Weiguang Bio
10.16.1 Weiguang Bio Plasma-derived Medical Product Basic Information
10.16.2 Weiguang Bio Plasma-derived Medical Product Product Overview
10.16.3 Weiguang Bio Plasma-derived Medical Product Product Market Performance
10.16.4 Weiguang Bio Business Overview
10.16.5 Weiguang Bio Recent Developments
10.17 Nanyue Bio
10.17.1 Nanyue Bio Plasma-derived Medical Product Basic Information
10.17.2 Nanyue Bio Plasma-derived Medical Product Product Overview
10.17.3 Nanyue Bio Plasma-derived Medical Product Product Market Performance
10.17.4 Nanyue Bio Business Overview
10.17.5 Nanyue Bio Recent Developments
10.18 KM Biologics
10.18.1 KM Biologics Plasma-derived Medical Product Basic Information
10.18.2 KM Biologics Plasma-derived Medical Product Product Overview
10.18.3 KM Biologics Plasma-derived Medical Product Product Market Performance
10.18.4 KM Biologics Business Overview
10.18.5 KM Biologics Recent Developments
11 Plasma-derived Medical Product Market Forecast by Region
11.1 Global Plasma-derived Medical Product Market Size Forecast
11.2 Global Plasma-derived Medical Product Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Plasma-derived Medical Product Market Size Forecast by Country
11.2.3 Asia Pacific Plasma-derived Medical Product Market Size Forecast by Region
11.2.4 South America Plasma-derived Medical Product Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Plasma-derived Medical Product by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Plasma-derived Medical Product Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Plasma-derived Medical Product by Type (2025-2032)
12.1.2 Global Plasma-derived Medical Product Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Plasma-derived Medical Product by Type (2025-2032)
12.2 Global Plasma-derived Medical Product Market Forecast by Application (2025-2032)
12.2.1 Global Plasma-derived Medical Product Sales (K MT) Forecast by Application
12.2.2 Global Plasma-derived Medical Product Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Plasma-derived Medical Product Market Size Comparison by Region (M USD)
Table 5. Global Plasma-derived Medical Product Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Plasma-derived Medical Product Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Plasma-derived Medical Product Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Plasma-derived Medical Product Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Medical Product as of 2022)
Table 10. Global Market Plasma-derived Medical Product Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Plasma-derived Medical Product Sales Sites and Area Served
Table 12. Manufacturers Plasma-derived Medical Product Product Type
Table 13. Global Plasma-derived Medical Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Plasma-derived Medical Product
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma-derived Medical Product Market Challenges
Table 22. Global Plasma-derived Medical Product Sales by Type (K MT)
Table 23. Global Plasma-derived Medical Product Market Size by Type (M USD)
Table 24. Global Plasma-derived Medical Product Sales (K MT) by Type (2019-2025)
Table 25. Global Plasma-derived Medical Product Sales Market Share by Type (2019-2025)
Table 26. Global Plasma-derived Medical Product Market Size (M USD) by Type (2019-2025)
Table 27. Global Plasma-derived Medical Product Market Size Share by Type (2019-2025)
Table 28. Global Plasma-derived Medical Product Price (USD/MT) by Type (2019-2025)
Table 29. Global Plasma-derived Medical Product Sales (K MT) by Application
Table 30. Global Plasma-derived Medical Product Market Size by Application
Table 31. Global Plasma-derived Medical Product Sales by Application (2019-2025) & (K MT)
Table 32. Global Plasma-derived Medical Product Sales Market Share by Application (2019-2025)
Table 33. Global Plasma-derived Medical Product Sales by Application (2019-2025) & (M USD)
Table 34. Global Plasma-derived Medical Product Market Share by Application (2019-2025)
Table 35. Global Plasma-derived Medical Product Sales Growth Rate by Application (2019-2025)
Table 36. Global Plasma-derived Medical Product Sales by Region (2019-2025) & (K MT)
Table 37. Global Plasma-derived Medical Product Sales Market Share by Region (2019-2025)
Table 38. North America Plasma-derived Medical Product Sales by Country (2019-2025) & (K MT)
Table 39. Europe Plasma-derived Medical Product Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Plasma-derived Medical Product Sales by Region (2019-2025) & (K MT)
Table 41. South America Plasma-derived Medical Product Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Plasma-derived Medical Product Sales by Region (2019-2025) & (K MT)
Table 43. Global Plasma-derived Medical Product Production (K MT) by Region (2019-2025)
Table 44. Global Plasma-derived Medical Product Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Plasma-derived Medical Product Revenue Market Share by Region (2019-2025)
Table 46. Global Plasma-derived Medical Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Plasma-derived Medical Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Plasma-derived Medical Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Plasma-derived Medical Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Plasma-derived Medical Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Takeda Plasma-derived Medical Product Basic Information
Table 52. Takeda Plasma-derived Medical Product Product Overview
Table 53. Takeda Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Takeda Business Overview
Table 55. Takeda Plasma-derived Medical Product SWOT Analysis
Table 56. Takeda Recent Developments
Table 57. CSL Plasma-derived Medical Product Basic Information
Table 58. CSL Plasma-derived Medical Product Product Overview
Table 59. CSL Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. CSL Business Overview
Table 61. CSL Plasma-derived Medical Product SWOT Analysis
Table 62. CSL Recent Developments
Table 63. Grifols Plasma-derived Medical Product Basic Information
Table 64. Grifols Plasma-derived Medical Product Product Overview
Table 65. Grifols Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Grifols Plasma-derived Medical Product SWOT Analysis
Table 67. Grifols Business Overview
Table 68. Grifols Recent Developments
Table 69. Octapharma Plasma-derived Medical Product Basic Information
Table 70. Octapharma Plasma-derived Medical Product Product Overview
Table 71. Octapharma Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Octapharma Business Overview
Table 73. Octapharma Recent Developments
Table 74. Kedrion Plasma-derived Medical Product Basic Information
Table 75. Kedrion Plasma-derived Medical Product Product Overview
Table 76. Kedrion Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Kedrion Business Overview
Table 78. Kedrion Recent Developments
Table 79. LFB Group Plasma-derived Medical Product Basic Information
Table 80. LFB Group Plasma-derived Medical Product Product Overview
Table 81. LFB Group Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. LFB Group Business Overview
Table 83. LFB Group Recent Developments
Table 84. Biotest Plasma-derived Medical Product Basic Information
Table 85. Biotest Plasma-derived Medical Product Product Overview
Table 86. Biotest Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Biotest Business Overview
Table 88. Biotest Recent Developments
Table 89. BPL Plasma-derived Medical Product Basic Information
Table 90. BPL Plasma-derived Medical Product Product Overview
Table 91. BPL Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. BPL Business Overview
Table 93. BPL Recent Developments
Table 94. RAAS Plasma-derived Medical Product Basic Information
Table 95. RAAS Plasma-derived Medical Product Product Overview
Table 96. RAAS Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. RAAS Business Overview
Table 98. RAAS Recent Developments
Table 99. CBPO Plasma-derived Medical Product Basic Information
Table 100. CBPO Plasma-derived Medical Product Product Overview
Table 101. CBPO Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. CBPO Business Overview
Table 103. CBPO Recent Developments
Table 104. Hualan Bio Plasma-derived Medical Product Basic Information
Table 105. Hualan Bio Plasma-derived Medical Product Product Overview
Table 106. Hualan Bio Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Hualan Bio Business Overview
Table 108. Hualan Bio Recent Developments
Table 109. Tiantan Bio Plasma-derived Medical Product Basic Information
Table 110. Tiantan Bio Plasma-derived Medical Product Product Overview
Table 111. Tiantan Bio Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Tiantan Bio Business Overview
Table 113. Tiantan Bio Recent Developments
Table 114. Shuanglin Bio Plasma-derived Medical Product Basic Information
Table 115. Shuanglin Bio Plasma-derived Medical Product Product Overview
Table 116. Shuanglin Bio Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Shuanglin Bio Business Overview
Table 118. Shuanglin Bio Recent Developments
Table 119. Boya Bio Plasma-derived Medical Product Basic Information
Table 120. Boya Bio Plasma-derived Medical Product Product Overview
Table 121. Boya Bio Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Boya Bio Business Overview
Table 123. Boya Bio Recent Developments
Table 124. Yuanda Shuyang Plasma-derived Medical Product Basic Information
Table 125. Yuanda Shuyang Plasma-derived Medical Product Product Overview
Table 126. Yuanda Shuyang Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Yuanda Shuyang Business Overview
Table 128. Yuanda Shuyang Recent Developments
Table 129. Weiguang Bio Plasma-derived Medical Product Basic Information
Table 130. Weiguang Bio Plasma-derived Medical Product Product Overview
Table 131. Weiguang Bio Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Weiguang Bio Business Overview
Table 133. Weiguang Bio Recent Developments
Table 134. Nanyue Bio Plasma-derived Medical Product Basic Information
Table 135. Nanyue Bio Plasma-derived Medical Product Product Overview
Table 136. Nanyue Bio Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Nanyue Bio Business Overview
Table 138. Nanyue Bio Recent Developments
Table 139. KM Biologics Plasma-derived Medical Product Basic Information
Table 140. KM Biologics Plasma-derived Medical Product Product Overview
Table 141. KM Biologics Plasma-derived Medical Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. KM Biologics Business Overview
Table 143. KM Biologics Recent Developments
Table 144. Global Plasma-derived Medical Product Sales Forecast by Region (2025-2032) & (K MT)
Table 145. Global Plasma-derived Medical Product Market Size Forecast by Region (2025-2032) & (M USD)
Table 146. North America Plasma-derived Medical Product Sales Forecast by Country (2025-2032) & (K MT)
Table 147. North America Plasma-derived Medical Product Market Size Forecast by Country (2025-2032) & (M USD)
Table 148. Europe Plasma-derived Medical Product Sales Forecast by Country (2025-2032) & (K MT)
Table 149. Europe Plasma-derived Medical Product Market Size Forecast by Country (2025-2032) & (M USD)
Table 150. Asia Pacific Plasma-derived Medical Product Sales Forecast by Region (2025-2032) & (K MT)
Table 151. Asia Pacific Plasma-derived Medical Product Market Size Forecast by Region (2025-2032) & (M USD)
Table 152. South America Plasma-derived Medical Product Sales Forecast by Country (2025-2032) & (K MT)
Table 153. South America Plasma-derived Medical Product Market Size Forecast by Country (2025-2032) & (M USD)
Table 154. Middle East and Africa Plasma-derived Medical Product Consumption Forecast by Country (2025-2032) & (Units)
Table 155. Middle East and Africa Plasma-derived Medical Product Market Size Forecast by Country (2025-2032) & (M USD)
Table 156. Global Plasma-derived Medical Product Sales Forecast by Type (2025-2032) & (K MT)
Table 157. Global Plasma-derived Medical Product Market Size Forecast by Type (2025-2032) & (M USD)
Table 158. Global Plasma-derived Medical Product Price Forecast by Type (2025-2032) & (USD/MT)
Table 159. Global Plasma-derived Medical Product Sales (K MT) Forecast by Application (2025-2032)
Table 160. Global Plasma-derived Medical Product Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Plasma-derived Medical Product
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma-derived Medical Product Market Size (M USD), 2019-2032
Figure 5. Global Plasma-derived Medical Product Market Size (M USD) (2019-2032)
Figure 6. Global Plasma-derived Medical Product Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma-derived Medical Product Market Size by Country (M USD)
Figure 11. Plasma-derived Medical Product Sales Share by Manufacturers in 2023
Figure 12. Global Plasma-derived Medical Product Revenue Share by Manufacturers in 2023
Figure 13. Plasma-derived Medical Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Plasma-derived Medical Product Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Plasma-derived Medical Product Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Plasma-derived Medical Product Market Share by Type
Figure 18. Sales Market Share of Plasma-derived Medical Product by Type (2019-2025)
Figure 19. Sales Market Share of Plasma-derived Medical Product by Type in 2023
Figure 20. Market Size Share of Plasma-derived Medical Product by Type (2019-2025)
Figure 21. Market Size Market Share of Plasma-derived Medical Product by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Plasma-derived Medical Product Market Share by Application
Figure 24. Global Plasma-derived Medical Product Sales Market Share by Application (2019-2025)
Figure 25. Global Plasma-derived Medical Product Sales Market Share by Application in 2023
Figure 26. Global Plasma-derived Medical Product Market Share by Application (2019-2025)
Figure 27. Global Plasma-derived Medical Product Market Share by Application in 2023
Figure 28. Global Plasma-derived Medical Product Sales Growth Rate by Application (2019-2025)
Figure 29. Global Plasma-derived Medical Product Sales Market Share by Region (2019-2025)
Figure 30. North America Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Plasma-derived Medical Product Sales Market Share by Country in 2023
Figure 32. U.S. Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Plasma-derived Medical Product Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Plasma-derived Medical Product Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Plasma-derived Medical Product Sales Market Share by Country in 2023
Figure 37. Germany Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Plasma-derived Medical Product Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Plasma-derived Medical Product Sales Market Share by Region in 2023
Figure 44. China Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Plasma-derived Medical Product Sales and Growth Rate (K MT)
Figure 50. South America Plasma-derived Medical Product Sales Market Share by Country in 2023
Figure 51. Brazil Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Plasma-derived Medical Product Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Plasma-derived Medical Product Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Plasma-derived Medical Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Plasma-derived Medical Product Production Market Share by Region (2019-2025)
Figure 62. North America Plasma-derived Medical Product Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Plasma-derived Medical Product Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Plasma-derived Medical Product Production (K MT) Growth Rate (2019-2025)
Figure 65. China Plasma-derived Medical Product Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Plasma-derived Medical Product Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Plasma-derived Medical Product Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Plasma-derived Medical Product Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Plasma-derived Medical Product Market Share Forecast by Type (2025-2032)
Figure 70. Global Plasma-derived Medical Product Sales Forecast by Application (2025-2032)
Figure 71. Global Plasma-derived Medical Product Market Share Forecast by Application (2025-2032)

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount